, while the value of microsurgery increased (R$ 7,022.31 to R$ 8,645.28, respectively) maior, apresentando, entretanto, tendência de queda deste valor (R$ 22.011,37 em 2010 para R$ 15.607,18 em 2015) enquanto o valor da microcirurgia aumentou (R$7.022,31 para R$ 8.645,28, respectivamente). Em relação ao desfecho óbito, a microcirurgia foi fator de risco (p-valor < 0,01 
Introduction
Intracerebral Aneurysms (IA) have prevalence between 0.2% and 9.9% among general population 1, and its rupture is a major cause of morbimortality around the world, being associated with mortality rates of approximately 50% 2, 3 . Moreover, half of the survivors persist with some degree of neurological deficit, which can lead to severe morbidity in 10-20% of the cases 4 .
In 1992, the treatment for IA was revolutionized with the introduction of endoscopic embolization with coils as an alternative, since for more than fifty years neurosurgery with clipping was the only modality of treatment available 2 . However, the turning point of aneurysms treatment occurred in 2002 with the publication of International Subarachnoid Aneurysm Trial (ISAT) 2, 3, 5 , a large study comparing these two treatments. It has shown that less invasive endoscopic alternative was associated with shorter hospitalization periods, fewer hemorrhagic complications post procedure and a 7.4% risk reduction of morbimortality in one year 6 .
The ISAT was highly criticized, mostly due to the inclusion of only 22% of the pre-selected candidates and the specific characteristic of the aneurysms analyzed 7 . Despite the incredibly favorable results towards endoscopic treatment, the methodological weak points of the study initiated a debate about the generalization of its results. Since then, many studies were made comparing these two methods, with controversial results being published along years 8, 9 , but, in spite of the heated scientific discussion, embolization gained gradually more space worldwide 10,11, especially after the publication of another large study with similar results to ISAT, the Barrow Ruptured Aneurysm Trial (BRAT) 12, 13 . Ten years after ISAT publication. Smith et al. 7 found that most of ruptured aneurysms were treated with endoscopic embolization in the United States, showcasing a worldwide trend of migration from the traditional forms of treatment to what some authors called 'endovascular era 14 .
According to the Brazilian Society of Diagnostic and Therapeutic Neuroradiology (Sociedade Brasileira de Neurorradiologia Diagnóstica e Terapêutica-SBNR) the national public health system database (DATASUS) shows that Brazil followed this trend of transition, contemplating a progressive increase in the number of endoscopic embolization procedures and consequently reduction in the number of clipping neurosurgery 15 . Notwithstanding, the publication of Ordinance 694 in December 24th of 2010 evocated a new round of discussion in the country by lowering the prices paid for the embolization materials used in the public health system (SUS) 16 , generating conflict with embolization coil suppliers.
Fifteen years after the publication of ISAT and seven after the publication of Ordinance 694 there are no studies in Brazil describing the reality of IA treatment in the country, or evaluating the impact of the cited ordinance in such scenario. Our study aims to compare endoscopic embolization with coils and neurosurgery with aneurysmal neck clipping in the Brazilian public health system, determining population characteristics of both procedures, and also identifying any change in the nationwide procedure choice post 2010.
Methods
This is an analytic observational study with secondary data from the Hospital Information System of SUS (Sistema de Informações Hospitalares do Departamento de Informática do Sistema Único de Saúde -SIH/DataSUS). We have collected data of all admissions for cerebral aneurysms treatment, including both clipping neurosurgery and endoscopic embolization in Brazil from 2010 to 2015. The terms used as parameters for research were the multiple SUS codes for each kind of treatment, as described in Table 1 
Results
In the period from 2010 to 2015, R$ 273 millions were expended with IC treatment in the Brazilian public health system (SUS), including endoscopic coil embolization and neurosurgery with neck clipping. A total of 19,856 hospitalizations were registered with average cost of R$ 13,759 and 11 days average length of stay. Considering both procedures, 1512 of cases resulted in death, corresponding to a mortality rate of 7.61%.
Embolization corresponded to 12,285 procedures (61.9%), but presented yearly reductions in the period, dropping from 2,536 hospitalizations in 2010 to 20,068 in 2015. Consequently the total price expended with the procedure in SUS also suffered reduction, from R$ 55 millions at the beginning of the period to R$ 32 millions in 2015. The cost per hospitalization varied from R$ 22,011.00 in 2010, dropping to the lowest value of R$ 15,061.00 and than raised back up to R$15,607.00 (reaching an average cost of R$ 17,261.00 and a reduction of 29.09% in the period). The average length of stay was 7.5 days, and 726 deaths were registered, resulting in a 5.91% mortality rate (Table 2) .
There were 7,571 hospitalizations for clipping treatment, corresponding to 38.1% of the total number of aneurysms treatments. Similarly to embolization, the total of procedures suffered yearly reductions, starting the period with 1543 on the first year analyzed and finishing with only 952 procedures in the last year. The total expense with this procedure dropped from approximately R$ 10,000 to a little less than R$ 8,000, despite the raise of 23,11% in cost per procedure (R$7.022,31 in 2010 and R$8.645,28 in 2015). The average length of stay was 16.6 days and 786 deaths were registered, resulting in a mortality rate of 10.38% (Table 3) .
Embolization represented a cost 3.47 times higher than clipping to SUS, partly due to the fact that it corresponds to a larger percentage of the total procedures, but mainly because of the cost per procedure, which were 2.14 times higher than neurosurgery. However, the length of stay and the mortality rate were lower in embolization ( Table 4 ). The number of embolization reduced by 18.5%, approximately half of the 38.3% reduction in the number of clipping, which resulted in a 25.96% in the total of IA treatment procedures in the country in these five years.
Having death as the worst possible outcome, we have that clipping was a risk factor in every year analyzed, with p < 0.001 and OR till 3.14 (95%), as shown in , characterizing the progressive decrease in coverage as a public hazard, that needs to be better confirmed and analyzed not only by the scientific community but also by the Brazilian government.
Observing the period, we noted that between 2010 and 2011 occurred the reverse of the pattern of other years, increasing in percentage of clipping and reducing of embolization. This fact might be attributed to the implementation of the Ordinance 694, having an immediate impact nationwide. Despite the recovery of the trend in following years, the absolute number of endovascular coiling continued to decline, which suggests that the trend has being held virtually by the astonishing decrease of 38.3% on the number of clipping procedure in the period, and not by a real transition from one form of treatment to another.
Actually, considering that the popularization and the access enlargement of CT and MRI tend to elevate the number of aneurysm diagnose, and also that every year rises the percentage of unruptured aneurysms undergoing endoscopic embolization, it was expected an important increase of this procedure, as seen around the world 6, 17, 18 . However, it is unrealistic to think that people simply stopped being treated, raising the hypothesis that is happening a migration of endoscopic procedures from the public health system to the private sector. In one hand this would diminish the impact of the elevated cost of the procedure to the government. In the other hand, aneurysms represent an important population problem that needs a nationwide strategy for prevention and treatment. Therefore, the public coverage of these patients should be improved, facilitating access to the treatment, and not to be transferred to the private sector.
Regarding the cost of the procedures Lad et al. 19 concluded that, even with smaller retreatment rates, clipping has higher initial costs (mainly due to the length of hospitalization) and is associated with more complications. However, they found that in the long term there is no statistical difference of cost
Discussion
In our sample an important reduction of clipping and a graduate rise in the percentage of endoscopic embolization was found in accordance to the world trend post ISAT 17 . In fact, Molyneux et al. (2015) 17 stated that 85% of the patients with ruptured aneurysm undergo embolization in the UK. Nevertheless embolization represented 76.03% of the total treatment procedures for both ruptured and unruptured aneurysm, which can lead us to the conclusion that the transition from clipping to endoscopic is also happening on unruptured aneurysms. This trend involving specifically unruptured aneurysms was reported by Brinjikji et al. (2011) 18 on a similar study in the United States.
The concerning result found in our study is the reduction of 29.35% on the total number of procedures from 2010 to 2015, Other studies 8, 20, 21 aiming the same analysis also demonstrated lower hospital cost in embolization due to smaller length of stay (7 days in clipping and 5 day in embolization, with cost of U$ 38,000 and U$ 33,400 respectively 8 ), in addition to better results in terms of clinical recovery. Nevertheless, in agreement to results mentioned previously, after one year follow-up there is no statistical difference in the cost of the two treatments.
We also observed a higher length of stay associated to neurosurgery with average of 16.6 days stay compared to 7.5 days in embolization. But we found conflicting data related to costs. Despite of a reduction on total cost of per procedure (including surgery and hospitalization costs) towards embolization, dropping from R$ 22,011.37 in 2010 to R$ 15,607.18 in 2015, it is still the double of the clipping procedure cost (R$ 7,022.31 in 2010 and R$ 8,645.28 in 2015). Therefore, considering that in all studies the cost of followup was higher after embolization, we can conclude that in Brazil embolization is much more expensive and bearing to SUS than clipping. Moreover, the cost difference tends to grow over time due to the requirement of regular angiographies, and particularly in ruptured aneurysms, and as Molyneux et al. 17 described an excess risk of recurrent subarachnoid hemorrhage up to 17.6 years after the initial hemorrhage. Wolstenholme et al. 2 attributed the high cost of the embolization procedure primary to coil cost, what may justify the price per procedure reduction observed in the period, once Ordinance 694 redefined the number of coils per procedure 15 .
Aside from economic issues, there are strong arguments towards the definition of endoscopic coiling as the first choice treatment based on better results involving complication prevention and clinical recovery 8, 9, 18, 22 . Nevertheless, the pre-treatment clinical status is a well established intra-and post procedure predictor, as emphasized in the majority of comparative studies, including the ISAT. In this context, factors like functional status, mobility and daily life independency, risk of death or rebleeding, occurrence of vasospasm, ischemia, and surgical or neurological complication are believed to be more dependable on conditions of the patient prior to the procedure than to the procedure itself 9, 11 . Other variables are also pointed as determinant to the clinical outcome, such as age, previous cerebrovascular ischemic disease, presence of other aneurismal symptoms and technical specificities of the patients' aneurysm, including size, location (anterior or posterior circulation) and complexity 23 .
Brinjikji . As a matter of fact, the authors of the cited study found a reduction of these rates more important in the coiling procedure, and hypothesized that it was a result of technical and instrumental evolution in all endovascular procedures, and suggested coiling as the first choice treatment in situations where both procedures were possible 18 .
These results might seem to tend in favor of embolization. However, more recently, McDonald et al. also studied American population and discovered that in a raw analysis it the data indeed show statistical difference, but after matching the groups in their demographic and clinical characteristics with propensity to the score adjustment, the variable 'death during hospitalization' becomes statistically indistinguishable between clipping and coiling groups. Furthermore, it was found that clipping patients were more likely to have an emergency admission (68% versus 61%). The authors hypothesized that whether variables such as Glasgow Coma Scale of the admission were taken in account, the differences could possibly disappear 6 .
Despite reaching the conclusion that surgical clipping of ruptured aneurysms was associated to higher peri-procedural risk of morbidity, the McDonald's study 6 raised interesting hypothesis for the differences found in our study. Moreover, it showed a 5% risk reduction of death or discharge to long-term care (similar to our result of 4.47%), while ISAT' results were 10.8%, which probably is due to the last one selection criteria.
In addition, when considering that recent studies are showing a higher risk of morbimortality in embolization patients with poorer pre-procedure status 2 or subarachnoid hemorrhage 24 , we question the generalization of ISAT's results.
All these considered, some benefits of endovascular treatment are undeniable, justifying the worldwide trendily and even natural transition from clipping to the less invasive procedure. However there are still problems to solve and evolution to be made in the endoscopic embolization treatment 14 , in such a way that is impossible to diminish the value of neurosurgery with neck clipping as a first line treatment, especially in Brazil, where the transition seems not to be as well defined as the rest of the world. In the "endovascular era" there are situations where open surgery is the first choice (larger aneurysms, thrombosed aneurysms, blood blister-like aneurysms, and aneurisms with hematoma), and it is the neurosurgeon responsibility not to be driven by trends, commercial influences or even belief, but by carefully evaluated scientific evidence.
Limitations
Despite our inclusion of a large sample of patients treated for intracranial aneurysms in Brazil, this is a retrospective study with secondary data, in which patients were not randomized or matched by epidemiological factors, what may expose the results to a significant potential for selection bias. Another possible limitation is the coding inaccuracies of the data, since they were acquired from the national public database, which depends on information provided by neurosurgeons with variable levels of experience and specialization, but this potential limitation is not different from other studies of cerebral aneurysms using this kind of data.
The absence of long term follow-up and other important clinical data may present as a limitation, but the inclusion of such information in the analysis consists a problem even in primary data studies. Also, the aim of this study was to characterize the general scenario of aneurysms treatment in Brazil, applying the arguments from both sides of the discussion to the Brazilian scenario, and not to give definitive proof of effectiveness for either.
Our findings do not invalidate or diminish the importance of randomized, multicenter, controlled trials such as ISAT, but instead, comes in agreement with many of its findings. And even points of incongruence with ISAT or BRAT reached comparable results to studies of different methodological design, which was seen by the authors as an indication of the value of such analysis.
